Antiviral AgentsAgenerase (amprenavir) Capsule and Solution
Drug Approval Classification: Labeling Supplement to Original New Drug Application (Approval Date: 8/02/02)
New Drug Interactions: The labeling for Agenerase has been changed to include:
Patients taking Agenerase should be instructed not to use hormonal contraceptives because some birth control pills (those containing ethinyl estradiol/norethindrone) have been found to decrease the concentration of amprenavir. Therefore, patients receiving hormonal contraceptives should be instructed to use alternate contraceptive measures during therapy with amprenavir.
Coadministration of Agenerase and methadone can decrease plasma levels of methadone.
Medscape Pharmacists. 2002;3(2) © 2002 Medscape
Cite this: September 2002 - Medscape - Sep 01, 2002.